Protocol SP902: A Historical-controlled, Multicenter, Double-blind, Randomized Trial to Assess the Efficacy and Safety of Conversion to Lacosamide 400 mg/day Monotherapy
|Effective start/end date||8/1/07 → 7/31/10|
- SCHWARZ BIOSCIENCES INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.